CUSIP: 87162T206
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
68,498,645
-
Share change
-
+2,129,857
-
Total reported value
-
$119,183,691
-
Put/Call ratio
-
152%
-
Price per share
-
$1.74
-
Number of holders
-
80
-
Value change
-
+$3,038,588
-
Number of buys
-
37
-
Number of sells
-
44
Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q3 2015
As of 30 Sep 2015,
SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,498,645 shares.
The largest 10 holders included
CAXTON CORP, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, FMR LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, NORTHERN TRUST CORP, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.